Statins and hypercholesterolaemia: UK Standing Medical Advisory Committee guidelines

Comment

A F Jones. Lancet. 1997.

. 1997 Oct 18;350(9085):1174-5.

doi: 10.1016/s0140-6736(05)63818-4.

No abstract available

Comment in

Drug therapy for coronary heart disease: the Sheffield table.
Wallis EJ, Ramsay LE, Jackson PR, Yeo WW, Williamson R. Wallis EJ, et al. Lancet. 1997 Dec 20-27;350(9094):1852. doi: 10.1016/s0140-6736(05)63671-9. Lancet. 1997. PMID: 9428275 No abstract available.
Drug therapy for coronary heart disease: the Sheffield table.
Poulter NR, Alberti KG, Beevers DG, Betteridge DJ, Campbell RW. Poulter NR, et al. Lancet. 1997 Dec 20-27;350(9094):1852-3. doi: 10.1016/s0140-6736(05)63672-0. Lancet. 1997. PMID: 9428276 No abstract available.
Drug therapy for coronary heart disease: the Sheffield table.
Colhoun H, Fuller J. Colhoun H, et al. Lancet. 1997 Dec 20-27;350(9094):1853-4. doi: 10.1016/S0140-6736(05)63673-2. Lancet. 1997. PMID: 9428277 No abstract available.
Drug therapy for coronary heart disease: the Sheffield table.
Vallance P, Martin J. Vallance P, et al. Lancet. 1997 Dec 20-27;350(9094):1854. doi: 10.1016/S0140-6736(05)63674-4. Lancet. 1997. PMID: 9428278 No abstract available.

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.
Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, Payne JN. Ramsay LE, et al. Lancet. 1996 Aug 10;348(9024):387-8. doi: 10.1016/s0140-6736(96)05516-x. Lancet. 1996. PMID: 8709740 No abstract available.